HDA_0622

Aprecia Pharmaceuticals

Purdue University and US Pharmacopeia launch webinar series on pharmaceutical 3D-printing

Purdue University and US Pharmacopeia launch webinar series on pharmaceutical 3D-printing

WEST LAFAYETTE, Ind. — Purdue University, in partnership with US Pharmacopeia and sponsorship from Aprecia Pharmaceuticals, announced a new pharmaceutical industry technology forum focused on 3D-Printing pharmaceutical medications and the benefits to patients, pharmaceutical executives, formulation scientists, and compounding pharmacists.  The forum will begin with a one-hour introduction session on September 14, 2021 and will continue monthly

3D printing is focus of Aprecia-Purdue partnership

3D printing is focus of Aprecia-Purdue partnership

BLUE ASH, Ohio — Health care is poised for a potential giant leap forward thanks to the 3D printing of medications. To advance the technology and science of 3D pharmaceutical printing, Purdue University’s College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications. “Aprecia’s mission is to

Spritam is first FDA-approved 3D printed drug

Spritam is first FDA-approved 3D printed drug

BLUE ASH, Ohio — Aprecia Pharmaceuticals Co. has received Food and Drug Administration approval for Spritam levetiracetam for oral use, an epilepsy treatment made using three-dimensional printing (3DP) technology. The company said Monday that the medication is the first drug product manufactured with 3DP technology that has been approved by the FDA. Spritam uses Aprecia’s